Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - gemfibrozil - oral tablet - 600mg

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - fenofibrate, quantity: 48 mg - tablet - excipient ingredients: lactose; sodium lauryl sulfate; hypromellose; croscarmellose sodium; magnesium stearate; purified water; xanthan gum; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid - fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia - types ii, iii, iv and v dyslipidaemia; dyslipidaemia associated with type 2 diabetes

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - fenofibrate, quantity: 145 mg - tablet - excipient ingredients: lactose; sodium lauryl sulfate; hypromellose; croscarmellose sodium; magnesium stearate; purified water; xanthan gum; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid - fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia - types ii, iii, iv and v dyslipidaemia; dyslipidaemia associated with type 2 diabetes

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - fenofibrate, quantity: 48 mg - tablet - excipient ingredients: lactose; sodium lauryl sulfate; hypromellose; croscarmellose sodium; magnesium stearate; purified water; xanthan gum; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid - fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia - types ii, iii, iv and v dyslipidaemia; dyslipidaemia associated with type 2 diabetes

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - fenofibrate, quantity: 145 mg - tablet - excipient ingredients: lactose; sodium lauryl sulfate; hypromellose; croscarmellose sodium; magnesium stearate; purified water; xanthan gum; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid - fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia - types ii, iii, iv and v dyslipidaemia; dyslipidaemia associated with type 2 diabetes

Singapore - engelsk - HSA (Health Sciences Authority)

euro asia medico pte. ltd. - fenofibrate (nanonized) - tablet - fenofibrate (nanonized) 145 mg

USA - engelsk - NLM (National Library of Medicine)

upsher-smith laboratories, inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.25 mg in 1 g

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - isotretinoin - 乳膏劑 - isotretinoin (8428000691) 0.5mg - isotretinoin - 粉刺、尋常性痤瘡。

Indonesien - indonesisk - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

abbott indonesia - indonesia - kapsul lepas tunda - 135 mg

Indonesien - indonesisk - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

pfizer indonesia - indonesia - piroxicam - gel - 0,5 %